New onset of generalized myasthenia gravis developed after a new coronavirus infection (COVID-19)-Reference-Cited by-同舟云学术

New onset of generalized myasthenia gravis developed after a new coronavirus infection (COVID-19)

Published:2021-12-27 Issue:4 Volume:13 Page:127-132
ISSN:2072-6732
Container-title:Journal Infectology
language:
Short-container-title:jour

Author:

Alekseeva T. M.¹,Isabekova P. Sh.¹,Topuzova M. P.¹,Skripchenko N. V.²

Affiliation:

1. National Medical Research Centre named after V.A. Almazov

2. Pediatric Research and Clinical Center for Infectious Diseases; Saint-Petersburg State Pediatric Medical University

Abstract

Development of various immune-mediated neurological complications after a viral infection is of particular interest to medical society during a pandemic of COVID-19. It was found that SARS-CoV-2 has the ability to cause hyperstimulation of the immune system, thereby initiating developing of autoimmune diseases. The article describes a clinical case of new onset of generalized myasthenia gravis with thymoma in a patient after previous COVID-19.

Publisher

SPRIDA

Subject

Infectious Diseases

Reference22 articles.

1. Ruan Q. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [Electronic resource] / Ruan Q. [et al.] // Intensive Care Medicine. — 2020. — Vol. 46, № 5. — P. 846-848.

2. Rojas M. Molecular mimicry and autoimmunity [Electronic resource] / M. Rojas [et al.] // Journal of Autoimmunity. — 2018. — Vol. 95. — P. 100-123.

3. Vojdani A. Potential antigenic cross-reactivity between SARSCoV-2 and human tissue with a possible link to an increase in autoimmune diseases [Electronic resource] / Vojdani A., Kharrazian D. // Clinical Immunology. — 2020. — Vol. 217. — P. 108480.

4. Vanderlugt C. L. Epitope spreading in immune-mediated diseases: implications for immunotherapy [Electronic resource] / Vanderlugt C.L., Miller S.D. // Nature Reviews Immunology. — 2002. — Vol. 2, № 2. — P. 85-95.

5. Ercolini A. M. The role of infections in autoimmune disease [Electronic resource] / Ercolini A.M., Miller S.D. // Clinical & Experimental Immunology. — 2009. — Vol. 155, № 1. — P. 1-15.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New coronavirus infection as a risk-factor for the development of tuberculosis: a clinical observation;Meditsinskiy sovet = Medical Council;2023-08-18

2. Predictors of length of hospital stay in patients with acute COVID-19;Journal Infectology;2023-04-19

3. Relationship between SARS-COV-2 And autoimmune neurological diseases;Journal Infectology;2022-07-13

4. Russian-language publication activity of medical researchers in during the COVID-19 pandemic: “post-COVID-19 syndrome”;Cardiovascular Therapy and Prevention;2022-07-08